Endothelial activation and stress index (EASIX) to predict engraftment syndrome after autologous hematopoietic cell transplantation in patients with multiple myeloma. A single center experience.
Saved in:
| Title: | Endothelial activation and stress index (EASIX) to predict engraftment syndrome after autologous hematopoietic cell transplantation in patients with multiple myeloma. A single center experience. |
|---|---|
| Authors: | Tolosa-Ridao C; Hematology Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain.; Facultat de Medicina, University of Barcelona, Barcelona, Spain., Cid J; Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Rodríguez-Lobato LG; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Charry P; Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Mateos JM; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Moreno-Castaño AB; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hemostasis and Erythropathology Lab, Hematopathology, Pathology Department, CDB, Hospital Clínic de Barcelona, Barcelona, Spain., Martinez-Sanchez J; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hemostasis and Erythropathology Lab, Hematopathology, Pathology Department, CDB, Hospital Clínic de Barcelona, Barcelona, Spain., Gallego C; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Llobet N; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Suárez-Lledó M; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Martínez-Roca A; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Muñoz BM; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Carreras E; Josep Carreras Institute against Leukemia (Campus Clinic), Barcelona, Spain., Bladé J; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Cibeira MT; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Larrea CF; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Rosiñol L; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Martínez C; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Díaz-Ricart M; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hemostasis and Erythropathology Lab, Hematopathology, Pathology Department, CDB, Hospital Clínic de Barcelona, Barcelona, Spain., Lozano M; Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain., Rovira M; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Fernández-Avilés F; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Salas MQ; Facultat de Medicina, University of Barcelona, Barcelona, Spain.; Hematology Department, Cancer Institute and Blood Disorders (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (14), pp. 2624-2632. Date of Electronic Publication: 2025 Oct 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2556179 |
